Which hedge funds own AMGN? AMGEN INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
12 of the hedge funds tracked by WhaleCreep disclosed a position in AMGN (AMGEN INC) in their Q2 2026 13F filings, worth $1.2bn in total. The largest holder by portfolio weight is Smead Capital Management at 5.1% of its book.
12tracked managers holding
0opened this quarter
0exited this quarter
Which hedge funds hold AMGN? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Smead Capital Management | Q2 2026 | 5.1% | $238.7m | 659,241 | -6% | reduced |
| Palogic Value Management | Q2 2026 | 1.0% | $2.8m | 7,793 | 0% | held |
| Ancora Advisors | Q2 2026 | 0.4% | $22.7m | 34,637 | -4% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.3% | $467.2m | 1,290,217 | 625% | added |
| Woodline Partners | Q2 2026 | 0.3% | $86.2m | 238,092 | 16% | added |
| Citadel Advisors | Q2 2026 | 0.1% | $254.9m | 703,984 | 281% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.1% | $6.8m | 18,788 | 267% | added |
| First Manhattan | Q2 2026 | 0.1% | $31.5m | 87,079 | -4% | reduced |
| Bridgewater Associates | Q2 2026 | 0.0% | $7.9m | 21,869 | 48% | added |
| Marshall Wace | Q2 2026 | 0.0% | $36.0m | 99,402 | -69% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $28.7m | 79,344 | -66% | reduced |
| Horizon Kinetics | Q2 2026 | 0.0% | $832.9k | 2,300 | -4% | reduced |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Boston Omaha | Q4 2024 | 0.1% |
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of AMGN changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 12 | $1.2bn |
| Q1 2026 | 12 | $703.7m |
| Q4 2025 | 8 | $429.8m |
| Q3 2025 | 9 | $400.9m |
| Q2 2025 | 9 | $452.3m |
| Q1 2025 | 9 | $550.3m |
| Q4 2024 | 13 | $539.5m |
| Q3 2024 | 11 | $560.6m |
| Q2 2024 | 12 | $599.9m |
| Q1 2024 | 12 | $477.8m |
| Q4 2023 | 12 | $467.5m |
| Q3 2023 | 13 | $470.6m |
| Q2 2023 | 12 | $477.2m |
| Q1 2023 | 10 | $674.2m |
| Q4 2022 | 10 | $806.3m |
| Q3 2022 | 7 | $432.3m |
Counts every tracked manager that disclosed AMGN in that quarter's filing, including managers that have since stopped filing.